References
- Mebrahtu Y, Lawyer P, Githure J, et al. Visceral leishmaniasis unresponsive to pentostam caused by Leishmania tropica in Kenya. Am J Trop Med Hyg 1989: 41(3): 289–94
- Peters BS, Fish D, Golden R, et al. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. QJ Med 1990: 77(283): 1101–11
- Mansour NS, Youssef FG, Mohareb EW, et al. Cutaneous leishmaniasis in the peace keeping force in East Sinai. J Egypt Soc Parasitol 1989: 19(2): 725–32
- al-Zahrani MA, Peters W, Evans DA. Visceral leishmaniasis in man and dogs in south-west Saudi Arabia. Trans R Soc Trop Med Hyg 1988: 82(6): 857
- Neal RA, Reeves A, Peters W. Leishmania infecting man and wild animals in Saudi Arabia. 7. Partial protection of mice against Leishmania major by prior infection with L. arabica. Trans R Soc Trop Med Hyg 1990: 84(2): 233–8
- Pearson RD, De Queiroz Sousa A. Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis. In: Mandell GL, Douglas G Jr, Bennett JE, eds. Principles and practice of infectious diseases. 3d ed. New York: Longman (Churchill Livingstone), 1990: 2066–77
- Hunter GW, ed. A manual of tropical medicine. 4th ed. Philadelphia: WB Saunders, 1966
- Maegraith B. Clinical tropical diseases. St Louis: Mosby—Year Book (Blackwell Scientific), 1989: 150–68
- Reed SG, Shreffler WG, Burns JM Jr, et al. An improved sérodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg 1990: 43(6): 632–9
- Bogdan C, Stosiek N, Fuchs H, et al. Detection of potentially diagnostic leishmanial antigens by western blot analysis of sera from patients with kala-azar or multilesional cutaneous leishmaniasis. (Letter) J Infect Dis 1990: 162(6): 1417–8
- Jaffe CL, Zalis M. Use of purified parasite proteins from Leishmania donovani for the rapid serodiagnosis of visceral leishmaniasis. J Infect Dis 1988: 157(6): 1212–20
- Ballou WR, McClain JB, Gordon DM, et al. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis. Lancet 1987: 2(8549): 13–6
- Oster CN, Chulay JD, Hendricks LD, et al. American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules. Am J Trop Med Hyg 1985: 34(5): 856–60
- Murray HW, Nathan CF. In vivo killing of intracellular visceral Leishmania donovani by a macrophage-targeted hydrogen peroxide-generating system. J Infect Dis 1988: 158(6): 1372–5
- Akuffo H, Kaplan G, Kiessling R, et al. Administration of recombinant interleukin-2 reduces the local parasite load of patients with disseminated cutaneous leishmaniasis. J Infect Dis 1990: 161(4): 775–80
- Convit J, Castellanos PL, Rondon A, et al. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis. Lancet 1987: 1(8530): 401–5